Atlas Trials

A Gene Therapy Study for Hemophilia B

Clinical trial NCT02484092 · COMPLETED

Trial details

NCT number
NCT02484092
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hemophilia B
Start date
2015-11-18
Primary completion
2019-04-08
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.